Cagrilintide (Cagri) is a novel amylin analogue developed for research into weight management, appetite regulation, and metabolic health. By mimicking the effects of the endogenous hormone amylin, it enhances satiety signals and works synergistically with other metabolic modulators such as GLP-1 receptor agonists.

Research Applications & Potential Effects:

• Studies on appetite suppression and reduced caloric intake

• Preclinical evaluation of body weight reduction

• Research into synergistic effects with GLP-1 receptor agonists

• Investigations into metabolic and cardiovascular health markers

Supplied as a sterile, lyophilised powder to ensure optimal purity and stability for precise experimental outcomes.

Molecular Formula: C187H291N51O59S
Molar Mass: 4213.73 g/mol
Form: Lyophilised powder
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 1384260-65-4